Axxion S.A.’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Axxion S.A.'s EW Position: Q3 2026 in Review
Axxion S.A. increased its Edwards Lifesciences (EW) stake by 42% in Q3 2026, buying an estimated $164K and bringing the position to 6,244 shares worth $539K. The position accounts for 0.04% of the portfolio, ranked #210.
Axxion S.A. first reported a position in EW in Q2 2026 and has held it in 2 quarters since. 1,340 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Axxion S.A. held 6,244 shares of Edwards Lifesciences worth $539K as of Q3 2026.
- Axxion S.A. bought 1,844 Edwards Lifesciences shares in Q3 2026, an estimated $164K.
- Edwards Lifesciences made up 0.04% of Axxion S.A.'s portfolio in Q3 2026, its #210 holding.
- Axxion S.A. first reported a position in Edwards Lifesciences in Q2 2026 and has held it in 2 quarters since.
- 1,340 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Axxion S.A.'s 13F filing for Q3 2026, filed 22 Oct 2026.